Kalbe Farma Tbk vs Chandra Asri Pacific Tbk. — how do they compare? Kalbe Farma Tbk trades at Rp720 (market cap 33T, 98.44M 24h volume), while Chandra Asri Pacific Tbk. trades at Rp1,930 (market cap 165.24T, 271.53M 24h volume). The key difference: Chandra Asri Pacific Tbk. is far larger — about 5× Kalbe Farma Tbk's market cap, and Chandra Asri Pacific Tbk. is more actively traded (271.53M versus 98.44M). Which is the better fit depends on your goals.
| KLBF | TPIA | |
|---|---|---|
Market Cap | 33T | 165.24T |
Volume | 98.44M | 271.53M |
Lot | 984.38K | 2.72M |
Turnover | 70.64B | 522.13B |
Average Price | 717.58 | 1,922.9 |
Value | 70.64B | 522.13B |
Indicative Equilibrium Price | 720 | 1,930 |
Indicative Equilibrium Volume | 43.62K | 69.58K |
Trailing returns across standard periods
Latest headlines on both assets
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Read more on TPIA →